18331-73-2Relevant articles and documents
THERAPEUTICALLY ACTIVE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER CHARACTERIZED AS HAVING AN IDH MUTATION
-
Page/Page column 105, (2011/06/26)
Compounds and compositions comprising compounds useful in the treatment of cancer are described herein. The compounds and compositions can be used to modulate an isocitrate dehydrogenase (IDH) mutant (e.g., IDHIm or IDH2m) having alpha hydroxyl neoactivity
Organic field-effect transistors based on solution-processible dibenzotetrathiafulvalene derivatives
Yoshino, Takamasa,Shibata, Koji,Wada, Hiroshi,Bando, Yoshimasa,Ishikawa, Ken,Takezoe, Hideo,Mori, Takehiko
supporting information; experimental part, p. 200 - 201 (2010/03/02)
Organic field-effect transistors based on alkyl-substituted dibenzotetrathiafulvalenes (DBTTF) are fabricated by solution process. The molecules with butyl or longer alkyl groups are standing perpendicular to the substrates in the thin films, and the tran
LIQUID-CRYSTAL 4H-3,1-BENZOXAZIN-4-ONES
Bolotin, B. M.,Zeryukina, L. S.,Safina, R. U.,Egorkin, V. V.,Kuliev, R. I.
, p. 996 - 998 (2007/10/02)
2,6-Disubstituted 4H-3,1-benzoxazin-4-ones that have mesogenic properties were synthesized by the reaction of 5-substituted anthranilic acid with aroyl chlorides in pyridine.The introduction of a 4H-3,1-benzoxazin-4-one fragment increases the absolute val
